research funding database


This opportunity is currently closed.

Sign up for Content alerts to stay informed when this or related funding opportunities are posted.

2024 Preclinical / Translational Studies (osteosarcoma | worldwide)

Share this post

Logo of scientifyRESEARCH and Enago "Author First, Quality First" scientifyRESEARCH recommends English editing and author support services from Enago.

The Preclinical / Translational Studies Grant from the Osteosarcoma Institute supports translational researchers working on osteosarcoma. The proposed study should have a research agenda that will identify biological dependencies in the disease that can be targeted in patients. This research agenda will ideally include the use of novel laboratory approaches and bioinformatic tools applied to osteosarcoma cells, a diversity of in vivo models across species and human patient samples. Furthermore, we believe these dependencies will likely impact a variety of potential phenotypes associated with the disease, including metastatic proclivity, DDR in the context of a structurally complex genome, and resistance to first generation T cell checkpoint blockade. Applications are open to researchers based at non-profit organizations worldwide. Applicants must have an MD, PhD, MD/PhD, or equivalent and be appointed as faculty (or equivalent) at an academic institution. Applicants may apply for up to 500,000 USD, including up to 10% indirect costs for 2 years.

Letters of intent are due on November 15, 2023. Invited full applications are due on April 12, 2024.

Adverts. Premium members do not see Google Ads.

Please Login / Subscribe to our premium membership to see the content. Sign up to Free trial to see detailed funding information.

non member

Sign-up for our monthly
research funding newsletter

you can unsubscribe at any time

Be the first to know

Sign-up for Personalized Grant Alerts